Oct 16, 2026 08:07AM
Oct 15, 2026 07:00AM
Oct 15, 2026 07:00AM
Oct 14, 2026 06:51AM
Oct 14, 2026 06:50AM
May 13, 2026 04:01PM
Mar 19, 2026 09:00AM Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors
Mar 17, 2026 09:00AM
Mar 13, 2026 09:00AM
Mar 11, 2026 07:01PM
Mar 10, 2026 09:00AM
Mar 4, 2026 04:01PM
Jan 9, 2026 07:02AM
Jan 9, 2026 07:00AM Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update
Nov 5, 2025 04:01PM
Oct 8, 2025 07:00AM
Oct 8, 2025 07:00AM
Sep 4, 2025 07:00AM
Sep 4, 2025 07:00AM
Aug 11, 2025 04:01PM
Jul 15, 2025 07:00AM Aquestive schedules Health Canada meeting for Anaphylm drug submission
Jul 15, 2025 07:00AM
Jun 17, 2025 06:39AM
Jun 16, 2025 07:02AM
Jun 16, 2025 07:00AM
May 13, 2025 03:26PM
May 12, 2025 04:01PM
Apr 12, 2024 04:01PM Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
Mar 5, 2024 05:05PM
Nov 6, 2023 04:37PM
Nov 6, 2023 04:37PM
Oct 9, 2023 08:00AM
Oct 9, 2023 08:00AM
Sep 11, 2023 08:02AM
Sep 11, 2023 08:00AM Aquestive Therapeutics Receives FDA Acceptance of New Drug Application (NDA) for Libervant™ (diazepam) Buccal Film in Pediatric Patients and Assignment of Prescription Drug User Fee Act (PDUFA) Date
Sep 6, 2022 04:04PM
Aug 2, 2022 04:02PM
Aug 2, 2022 04:02PM
May 17, 2022 04:01PM
May 17, 2022 04:01PM
May 17, 2022 04:01PM
May 3, 2022 05:41PM Aquestive Therapeutics Inc. (AQST) Reports Q1, Provides Business Update
May 3, 2022 05:40PM
May 3, 2022 05:40PM
Mar 10, 2022 06:38AM
Mar 8, 2022 04:57PM
Mar 8, 2022 04:56PM
Mar 8, 2022 04:56PM
Dec 21, 2021 05:15AM Aquestive Therapeutics (AQST) Announces FDA Will Not Be Ready to Take Action by December 23, 2021 for the Company’s NDA for Libervant Buccal Film
Dec 20, 2021 10:49PM

15,942 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All